ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 67

The Oxygen Sensor PHD1 Is an Indispensable Regulator of Arthritis Development

Katelijne De Wilde1, Peggy Jacques2 and Dirk Elewaut3, 1Inflammation Research Center - VIB UGhent, Molecular Immunology and Inflammation Unit, Ghent, Belgium, 2Ghent University Hospital, Ghent, Belgium, 3VIB Inflammation Research Center, University of Ghent, Ghent, Belgium

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, cytokines and rheumatic disease

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Biology and Pathology of Bone and Joint Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Oxygen supply is a fundamental requirement for all living tissues. Some tissues such as articular joints are characterized by a physiological state of hypoxia. Interestingly, under conditions of inflammation such as in arthritic disease, this level of hypoxia is even further enhanced. However, the functional significance of these observations and the molecular mechanisms involved remain poorly characterized to date. We therefore examined the role of 3 known oxygen sensors, prolyl hydroxylase domain (PHD) proteins: PHD1, PHD2 and PHD3. They are enzymes whose function is essentially controlled by oxygen. Their expression pattern varies between either of them and all of them have been ascribed specific roles in a myriad of biological processes. Our goal was to examine the role of oxygen sensors PHD1, PHD2 and PHD3 in preclinical models of rheumatoid arthritis, and to delineate the cellular source involved.

Methods: We subjected the collagen antibody induced arthritis (CAIA) model (resembling rheumatoid arthritis) to hypoxic (10% O2) and normoxic conditions (21% O2), respectively. Furthermore, the CAIA-model was induced in mice with germline deficiency of the specific PHD’s and in mice with a myeloid cell-specific PHD1 deficiency versus controls. Arthritis development was assessed by clinical scoring of paw swelling, histopathology of knee joints and μCT.

Results: Mice kept in hypoxic conditions during CAIA experiments showed markedly less arthritis (both by clinical and histopathological assessment) compared to mice in normoxic conditions. Furthermore, we demonstrated that PHD1 knock-out (KO) mice had significantly less joint inflammation compared to wildtype mice. PHD1 KO mice were also protected against inflammation induced bone loss as evidenced by μCT. By contrast, no differences were found between PHD2 heterozygous (PHD2 KO mice are not viable) or PHD3 KO mice and littermate controls. Because myeloid cells are considered critical effector cells upon passive transfer of arthritogenic antibodies in the CAIA model we also generated myeloid cell specific ko mice (PHD1myelKO). Of interest, PHD1myelKO mice developed less arthritis compared to wildtype mice and were protected against inflammation induced bone loss.

Conclusion: Our data are consistent with a new paradigm that the oxygen sensor PHD1 is a critical regulator of myeloid cell function in arthritic disease. Overall, the data suggest that PHD1 is a potential target in the treatment of arthritis.


Disclosure: K. De Wilde, None; P. Jacques, None; D. Elewaut, Scientific Research Flanders; Research Council Ghent University; Interuniversity Attraction Pole., 2,Boehringer Ingelheim; Pfizer; UCB; Merck; Novartis; Janssen; Abbvie, 5.

To cite this abstract in AMA style:

De Wilde K, Jacques P, Elewaut D. The Oxygen Sensor PHD1 Is an Indispensable Regulator of Arthritis Development [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-oxygen-sensor-phd1-is-an-indispensable-regulator-of-arthritis-development/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-oxygen-sensor-phd1-is-an-indispensable-regulator-of-arthritis-development/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology